Difference between revisions of "Prednisone (Sterapred)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Coagulopathy medications" to "Category:Acquired coagulopathy medications") |
m |
||
| Line 34: | Line 34: | ||
*[[Myelofibrosis]] | *[[Myelofibrosis]] | ||
*[[Peripheral T-cell lymphoma]] | *[[Peripheral T-cell lymphoma]] | ||
| + | *[[Post-transplant lymphoproliferative disorder]] | ||
*[[Primary mediastinal B-cell lymphoma]] | *[[Primary mediastinal B-cell lymphoma]] | ||
*[[Prostate cancer]] | *[[Prostate cancer]] | ||
| Line 39: | Line 40: | ||
*[[Thymoma]] | *[[Thymoma]] | ||
*[[Transformed lymphoma]] | *[[Transformed lymphoma]] | ||
| − | |||
*[[Waldenström macroglobulinemia]] | *[[Waldenström macroglobulinemia]] | ||
</div> | </div> | ||
| Line 132: | Line 132: | ||
|Prednison-GF | |Prednison-GF | ||
|Prednisona | |Prednisona | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|Prednison Hexal | |Prednison Hexal | ||
| Line 214: | Line 196: | ||
[[Category:Myelofibrosis medications]] | [[Category:Myelofibrosis medications]] | ||
[[Category:Peripheral T-cell lymphoma medications]] | [[Category:Peripheral T-cell lymphoma medications]] | ||
| + | [[Category:Post-transplant lymphoproliferative disorder medications]] | ||
[[Category:Primary mediastinal B-cell lymphoma medications]] | [[Category:Primary mediastinal B-cell lymphoma medications]] | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
| Line 219: | Line 202: | ||
[[Category:Thymoma medications]] | [[Category:Thymoma medications]] | ||
[[Category:Transformed lymphoma medications]] | [[Category:Transformed lymphoma medications]] | ||
| − | |||
[[Category:Waldenström macroglobulinemia medications]] | [[Category:Waldenström macroglobulinemia medications]] | ||
[[Category:Drugs FDA approved in 1955]] | [[Category:Drugs FDA approved in 1955]] | ||
[[Category:WHO Essential Cancer Medicine]] | [[Category:WHO Essential Cancer Medicine]] | ||
Revision as of 03:12, 28 January 2018
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Acute promyelocytic leukemia
- Adult T-cell leukemia-lymphoma
- Anaplastic large cell lymphoma
- Autoimmune thrombocytopenic purpura (ITP)
- B-cell acute lymphoblastic leukemia
- Burkitt lymphoma
- Chronic lymphocytic leukemia (CLL/SLL)
- Acquired coagulopathy
- Diffuse large B-cell lymphoma
- Erdheim-Chester disease
- Follicular lymphoma
- HIV-associated lymphoma
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Hodgkin lymphoma
- Langerhans cell histiocytosis
- Large granular lymphocytic leukemia
- Mantle cell lymphoma
- Marginal zone lymphoma
- Mast cell diseases
- Mediastinal gray-zone lymphoma
- Multiple myeloma
- Myelodysplastic syndrome
- Myelofibrosis
- Peripheral T-cell lymphoma
- Post-transplant lymphoproliferative disorder
- Primary mediastinal B-cell lymphoma
- Prostate cancer
- T-cell acute lymphoblastic leukemia
- Thymoma
- Transformed lymphoma
- Waldenström macroglobulinemia
Patient drug information
- Prednisone (Sterapred) patient drug information (Chemocare)[3]
- Prednisone (Sterapred) patient drug information (UpToDate)[4]
Also known as
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| APO-Prednisone | APO-Prenisona | APO Prednison | Artinizona | Artrizona | BE-Tabs Prednisone | Becortem | Bersen |
| Colisone | Cortancyl | Corticorten | Cortigen | Cortiol | Cortiprex | Cutason | Dacortin |
| Decortancyl | Decortin | Decortisyl | Dehydrocortison | Delcortin | Dellacorta | Delta-Cortisone | Delta Cortelan |
| Deltacortene | Deltacortone | Deltason | Deltasone | Deltisona | DI Adreson | Dispersona | DLI-Prednisone |
| Drazone | Econosone | Ednaprom | Encorton | Erlanison | Flamacorten | Hostacortin | Ifison |
| Isolone | Liquid Pred | Liquid Prednisone | Lisacort | ME Korti | Meticorten | Nisocortec | Nisona |
| Nisone | Nizon | Nosipren | Novoprednisone | Orasone | Panafcort | Panasol-S | Pehacort |
| Pharmapred | Precortil | Predcort | Predeltin | Predicor | Predicorten | Predinis | Preditec |
| Prednax | Prednicap | Prednicen-M | Prednilonga-Retard | Predniment | Prednison | Prednison-GF | Prednisona |
| Prednison Hexal | Prednison Leciva | Prednison Nurison | Prednison Ratiopharm | Prednison Sandoz | Prednison Streuli | Prednisonum | Prednitone |
| Predson | Predsone | Predval | Procion | Prolix | Pronison | Pulmison | Rectodelt |
| Senterlic | SK-Prednisone | Sone | Steerometz | Sterapred | Sterapred DS | Trolic | Ultracorten |
| Vitazon | Winpred | ||||||
References
Categories:
- Drug index
- Oral medications
- Immunosuppressants
- Steroids
- Acute promyelocytic leukemia medications
- Adult T-cell leukemia-lymphoma medications
- Anaplastic large cell lymphoma medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Chronic lymphocytic leukemia (CLL/SLL) medications
- Acquired coagulopathy medications
- Diffuse large B-cell lymphoma medications
- Erdheim-Chester disease medications
- Follicular lymphoma medications
- HIV-associated lymphoma medications
- Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Immune thrombocytopenic purpura (ITP) medications
- Langerhans cell histiocytosis medications
- Large granular lymphocytic leukemia medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Mediastinal gray-zone lymphoma medications
- Multiple myeloma medications
- Myelodysplastic syndrome medications
- Myelofibrosis medications
- Peripheral T-cell lymphoma medications
- Post-transplant lymphoproliferative disorder medications
- Primary mediastinal B-cell lymphoma medications
- Prostate cancer medications
- T-cell acute lymphoblastic leukemia medications
- Thymoma medications
- Transformed lymphoma medications
- Waldenström macroglobulinemia medications
- Drugs FDA approved in 1955
- WHO Essential Cancer Medicine